HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration

• Michal Mielcarek,

  Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

  ⨯
• Christian Landles,

  Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

  ⨯
• Andreas Weiss,

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience Discovery, Basel, Switzerland

  ⨯
• Amyaouch Bradaia,

  Affiliation Neuroservice, Aix en Provence, France

  ⨯
• Tamara Seredenina,

  Affiliation Brain Mind Institute, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland

  ⨯
• Linda Inuabasi,

  Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

  ⨯
• Georgina F. Osborne,

  Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

  ⨯
• Kristian Wadel,

  Affiliation Neuroservice, Aix en Provence, France

  ⨯
• Chrystelle Touller,

  Affiliation Neuroservice, Aix en Provence, France

  ⨯
• Rachel Butler,

  Current address: Nuffield Laboratory of Ophthalmology, University of Oxford, The John Radcliffe Hospital, Oxford, United Kingdom.

  Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

  ⨯
• Janette Robertson,

  Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

  ⨯
• Sophie A. Franklin,

  Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

  ⨯
• Donna L. Smith,

  Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

  ⨯
• Larry Park,

  Affiliation CHDI Management Inc./CHDI Foundation, Los Angeles, California, United States of America

  ⨯
• Paul A. Marks,

  Affiliation Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Erich E. Wanker,

  Affiliation Neuroproteomics, Max Delbrueck Center for Molecular Medicine, Berlin, Germany

  ⨯
• Eric N. Olson,

  Affiliation Department of Molecular Biology, Southwestern University, Dallas, Texas, United States of America

  ⨯
• Ruth Luthi-Carter,

  Affiliation Brain Mind Institute, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland

  ⨯
• Herman van der Putten,

  Affiliation Novartis Institutes for BioMedical Research, Neuroscience Discovery, Basel, Switzerland

  ⨯
• Vahri Beaumont,

  Affiliation CHDI Management Inc./CHDI Foundation, Los Angeles, California, United States of America

  ⨯
•  [ ... ],
• Gillian P. Bates

  * E-mail: gillian.bates@kcl.ac.uk

  Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom

  ⨯
• [ view all ]
• [ view less ]